Prognostic Impact of Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance in Myocarditis: A Systematic Review and Meta-Analysis
- PMID: 33441003
- DOI: 10.1161/CIRCIMAGING.120.011492
Prognostic Impact of Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance in Myocarditis: A Systematic Review and Meta-Analysis
Abstract
Background: Patients with acute myocarditis (AM) are at increased risk of adverse cardiac events after the index episode. Late gadolinium enhancement (LGE) detected by cardiovascular magnetic resonance in patients with AM plays an important diagnostic role, but its prognostic significance remains unresolved. This systematic review and meta-analysis sought to assess the prognostic implications of cardiovascular magnetic resonance-derived LGE in patients with AM.
Methods: Data search was conducted from inception through February 28, 2020, using the following Medical Subject Heading terms: Myocarditis, CMR, Magnetic Resonance Imaging, Magnetic Resonance. From 2422 articles retrieved, we selected 11 studies reporting baseline cardiovascular magnetic resonance assessment and long-term clinical follow-up in patients with AM. Hazard ratios and CIs for a combined clinical end point were recorded for LGE presence, extent (>2 segments or >10% of left ventricular [LV] mass or >17g) and location (anteroseptal versus non-anteroseptal). A combined end point comprised all-cause mortality, cardiac mortality, and major adverse cardiovascular events. Hartung and Knapp correction improved robustness of the results. Prespecified sensitivity analyses explored potential sources of heterogeneity. The meta-analysis was conducted according to the Meta-analysis of Observational Studies in Epidemiology guidelines.
Results: LGE presence (pooled hazard ratios, 3.28 [95% CIs, 1.69-6.39], P<0.001 [95% CIs, 1.33-8.11] after Hartung and Knapp correction) and anteroseptal LGE (pooled-hazard ratios, 2.58 [95% CIs, 1.87-3.55], P<0.001 [95% CIs, 1.64-4.06] after Hartung and Knapp correction) were associated with an increased risk of the combined end point. Extensive LGE was associated with worse outcomes (pooled-hazard ratios, 1.96 [95% CIs, 1.08-3.56], P=0.027), but this association was not confirmed after Hartung and Knapp correction (95% CIs, 0.843-4.57).
Conclusions: LGE presence and anteroseptal location at baseline cardiovascular magnetic resonance are important independent prognostic markers that herald an increased risk of adverse cardiac outcomes in patients with AM. Registration: https://www.crd.york.ac.uk/PROSPERO/ Unique identifier: CRD42019146619.
Keywords: magnetic resonance imaging; meta-analysis; myocarditis; prognosis; systematic review.
Similar articles
-
Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis.Int J Cardiol. 2017 Mar 15;231:216-221. doi: 10.1016/j.ijcard.2016.11.282. Epub 2016 Nov 23. Int J Cardiol. 2017. PMID: 27913009
-
Prevalence and Prognostic Impact of Septal Late Gadolinium Enhancement in Acute Myocarditis With or Without Preserved Left Ventricular Function.Am J Cardiol. 2018 Dec 1;122(11):1955-1958. doi: 10.1016/j.amjcard.2018.08.038. Epub 2018 Sep 13. Am J Cardiol. 2018. PMID: 30266253
-
Significance of Anteroseptal Late Gadolinium Enhancement Among Patients With Acute Myocarditis.Am J Cardiol. 2023 Jul 15;199:18-24. doi: 10.1016/j.amjcard.2023.04.012. Epub 2023 May 23. Am J Cardiol. 2023. PMID: 37229967
-
The prognostic value of late gadolinium enhancement in myocarditis and clinically suspected myocarditis: systematic review and meta-analysis.Eur Radiol. 2020 May;30(5):2616-2626. doi: 10.1007/s00330-019-06643-5. Epub 2020 Feb 10. Eur Radiol. 2020. PMID: 32040731
-
Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis.JACC Cardiovasc Imaging. 2023 Mar;16(3):345-357. doi: 10.1016/j.jcmg.2022.10.018. Epub 2023 Jan 11. JACC Cardiovasc Imaging. 2023. PMID: 36752432
Cited by
-
Cardiac Magnetic Resonance in Heart Failure: Diagnostic and Prognostic Assessments.J Cardiovasc Dev Dis. 2025 May 23;12(6):200. doi: 10.3390/jcdd12060200. J Cardiovasc Dev Dis. 2025. PMID: 40558635 Free PMC article. Review.
-
Imaging predictors of adverse prognosis in Fabry disease cardiomyopathy: A systematic review and meta-analysis.Eur J Clin Invest. 2025 May;55(5):e14388. doi: 10.1111/eci.14388. Epub 2025 Jan 22. Eur J Clin Invest. 2025. PMID: 39840688 Free PMC article.
-
Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology-A PROLONG-II Substudy.Sensors (Basel). 2022 Mar 5;22(5):2037. doi: 10.3390/s22052037. Sensors (Basel). 2022. PMID: 35271182 Free PMC article.
-
Value of a short non-contrast CMR protocol in MINOCA.Eur Radiol. 2024 Feb;34(2):994-1002. doi: 10.1007/s00330-023-10096-2. Epub 2023 Aug 15. Eur Radiol. 2024. PMID: 37581660 Free PMC article.
-
Myocardial fibrosis by T1 mapping magnetic resonance imaging predicts incident cardiovascular events and all-cause mortality: the Multi-Ethnic Study of Atherosclerosis.Eur Heart J Cardiovasc Imaging. 2022 Sep 10;23(10):1407-1416. doi: 10.1093/ehjci/jeac010. Eur Heart J Cardiovasc Imaging. 2022. PMID: 35147665 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources